Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Free Cash Flow Generation Index
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Free Cash Flow Generation Index of 0.86x as of September 2025. Free cash flow of CN¥418.93 Million represents 1% of operating cash flow (CN¥486.04 Million). Explore capital reinvestment ratio of Shanghai Shyndec Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shanghai Shyndec Pharmaceutical Co Ltd Free Cash Flow Generation Index (2004–2025)
Historical FCF Generation Index trend for Shanghai Shyndec Pharmaceutical Co Ltd across 22 annual periods. For the full cash flow conversion analysis, see Shanghai Shyndec Pharmaceutical Co Ltd cash conversion from operations.
Annual Free Cash Flow Generation for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2025)
Year-by-year Free Cash Flow Generation Index for Shanghai Shyndec Pharmaceutical Co Ltd. Check 600420 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.84x | CN¥1.43 Billion | CN¥1.70 Billion | CN¥263.83 Million | ▼ -6.4% |
| 2024 | 0.90x | CN¥2.04 Billion | CN¥2.26 Billion | CN¥219.77 Million | ▲ +13.9% |
| 2023 | 0.79x | CN¥1.36 Billion | CN¥1.72 Billion | CN¥357.19 Million | ▼ -11.2% |
| 2022 | 0.89x | CN¥2.55 Billion | CN¥2.86 Billion | CN¥307.44 Million | ▲ +29.4% |
| 2021 | 0.69x | CN¥1.16 Billion | CN¥1.68 Billion | CN¥521.44 Million | ▼ -9.0% |
| 2020 | 0.76x | CN¥1.18 Billion | CN¥1.56 Billion | CN¥377.98 Million | ▲ +11.1% |
| 2019 | 0.68x | CN¥866.32 Million | CN¥1.27 Billion | CN¥403.82 Million | ▼ -10.3% |
| 2018 | 0.76x | CN¥1.27 Billion | CN¥1.67 Billion | CN¥399.40 Million | ▼ -18.0% |
| 2017 | 0.93x | CN¥2.15 Billion | CN¥2.31 Billion | CN¥168.44 Million | ▲ +30.2% |
| 2016 | 0.71x | CN¥597.27 Million | CN¥838.58 Million | CN¥241.30 Million | ▲ +2150.6% |
| 2015 | -0.03x | CN¥-7.87 Million | CN¥226.65 Million | CN¥234.52 Million | ▲ +94.8% |
| 2014 | -0.67x | CN¥-172.02 Million | CN¥258.51 Million | CN¥430.53 Million | ▲ +54.8% |
| 2013 | -1.47x | CN¥-305.13 Million | CN¥207.50 Million | CN¥512.62 Million | ▼ -34.1% |
| 2012 | -1.10x | CN¥-212.11 Million | CN¥193.41 Million | CN¥405.52 Million | ▼ -2033.3% |
| 2011 | 0.06x | CN¥7.72 Million | CN¥136.12 Million | CN¥128.40 Million | ▲ +116.0% |
| 2010 | -0.36x | CN¥-40.91 Million | CN¥115.11 Million | CN¥156.02 Million | ▼ -152.4% |
| 2009 | 0.68x | CN¥66.14 Million | CN¥97.43 Million | CN¥31.29 Million | ▼ -11.4% |
| 2008 | 0.77x | CN¥44.49 Million | CN¥58.04 Million | CN¥13.56 Million | ▲ +31.8% |
| 2007 | 0.58x | CN¥47.86 Million | CN¥82.31 Million | CN¥34.45 Million | ▲ +268.9% |
| 2006 | 0.16x | CN¥11.60 Million | CN¥73.60 Million | CN¥62.00 Million | ▲ +166.4% |
| 2005 | -0.24x | CN¥-13.75 Million | CN¥57.90 Million | CN¥71.65 Million | ▼ -429.2% |
| 2004 | 0.07x | CN¥1.23 Million | CN¥17.02 Million | CN¥15.79 Million | — |